1-5 of 5
Stephan Bohl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Menin Inhibitor Ziftomenib (KO-539) Synergizes with Agents Targeting Chromatin Regulation or Apoptosis and Sensitizes AML with MLL Rearrangement or NPM1 Mutation to Venetoclax

Johanna Rausch, Margarita M. Dzama, Nadezda Dolgikh, Hanna Stiller, Stephan Bohl, Catharina Lahrmann, Kerstin Kunz, Linda Kessler, Hakim Echchannaoui, Chun-Wei David Chen, Thomas Kindler, Francis Burrows, Matthias Theobald, Daniel Sasca, Scott A. Armstrong, Michael Kuehn
Journal: Blood
Blood (2022) 140 (Supplement 1): 6226–6227.
https://doi.org/10.1182/blood-2022-167566
Published: 2022
Journal Articles

Quantitative Proteomic Analysis of Relapsed Multiple Myeloma Identifies CDK6 Upregulation As a Potential Targetable Resistance Mechanism for Lenalidomide

Yuen Lam Dora Ng, Stephan Bohl, Evelyn Ramberger, Oliver Popp, Imke Bauhuf, Anna Dolnik, Christian Steinebach, Michael Gütschow, Lars Bullinger, Philipp Mertins, Jan Kroenke
Journal: Blood
Blood (2019) 134 (Supplement_1): 2567.
https://doi.org/10.1182/blood-2019-130682
Published: 2019
Journal Articles

Exome Sequencing of Relapsed Multiple Myeloma Combined with Pooled CRISPR/Cas9 Screens Identifies Gene Mutations Associated with Drug-Specific Resistance

Stephan Bohl, Laura K. Schmalbrock, MD, Imke Bauhuf, Anna Dolnik, Tamara J. Blätte, MSc, Stefanie Lindner, Dr., Tatjana Meyer, MSc, BSc, Sarah Knödler, Denise Miller, Miriam Kull, Christian Langer, MD, Hartmut Döhner, MD, Dirk Heckl, PhD, Lars Bullinger, Jan Krönke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 809.
https://doi.org/10.1182/blood-2019-131245
Published: 2019
Journal Articles

Whole Exome Sequencing Reveals High Genetic Diversity in Relapsed Multiple Myeloma

Laura K. Schmalbrock, MD, Stephan Bohl, MD, Anna Dolnik, PhD, Tamara J. Blätte, MSc, Maria-Veronica Teleanu, Miriam Kull, MD, Denise Miller, Lars Bullinger, MD, Christian Langer, MD, Jan Kronke
Journal: Blood
Blood (2017) 130 (Supplement 1): 4363.
https://doi.org/10.1182/blood.V130.Suppl_1.4363.4363
Published: 2017
Journal Articles

Reduced Intensity Conditioning with Fludarabine, BCNU and Melphalan (FBM) for Allogeneic Hematopoietic Cell Transplantation in Elderly AML Patients: Factors Predicting Outcome

Verena Wais, Stephan Bohl, Lukas Kündgen, Stephanie von Harsdorf, Katrina Scholl, Richard F. Schlenk, MD, Susanne Hofmann, C. Philipp Maier, Konstanze Döhner, MD, Maria-Veronica Teleanu, MD, Lars Bullinger, MD, Kathrin Drognitz, Jean-Charles Moulin, Martin Binnenhei, Martin Bentz, MD, Hartmut Döhner, MD, Donald Bunjes, MD, Mark Ringhoffer, MD, Florian Kuchenbauer, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5523.
https://doi.org/10.1182/blood.V126.23.5523.5523
Published: 2015